SCHEMBL20119103

SCHEMBL20119103

Cc1cc(-c2nnn(C)n2)cc(C)c1N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.46
TP53 P04637 1/20 0.46
CYP3A4 P08684 1/20 0.46
TSHR P16473 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
EPHX2 P34913 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 2/20 0.35
NPC1 O15118 1/20 0.35
NFKB1 P19838 1/20 0.35
RAB9A P51151 1/20 0.35
NFKB2 Q00653 1/20 0.35
RELA Q04206 1/20 0.35
PPARA Q07869 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
POLB P06746 1/20 0.32
DRD2 P14416 1/20 0.32
LTA4H P09960 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22911187 0.85 RAB9A (0.36) TP53EPHX2SMN1; SMN2NPC1NFKB1
SCHEMBL8553788 0.81 CA1 (0.46) TP53EPHX2SMN1; SMN2NPC1NFKB1
SCHEMBL15261817 0.81 RAB9A (0.35) TP53EPHX2SMN1; SMN2NPC1NFKB1
SCHEMBL20202273 0.79 HRH4 (0.38) TP53EPHX2SMN1; SMN2LMNANPC1
SCHEMBL3343755 0.77 RAB9A (0.44) ALDH1A1CYP3A4TSHRTDP1EPHX2
SCHEMBL30123049 0.76 TRPM8 (0.40) TSHRSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL1460083 0.74 RAB9A (0.38) ALDH1A1EPHX2SMN1; SMN2NPC1NFKB1
SCHEMBL6609423 0.74 TRPV1 (0.42) TP53TDP1SMN1; SMN2NPC1NFKB1
SCHEMBL8215849 0.73 SMN1; SMN2 (0.47) EPHX2SMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL1674237 0.73 SMN1; SMN2 (0.62) ALDH1A1TP53CYP3A4TDP1EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3573959-B1 BENZYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-07-28 EP disclosed
EP-3573965-B1 INDANYLAMINOPYRAZINYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-06-23 EP disclosed
EP-3544958-B1 INDANYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-03-24 EP disclosed
EP-3532458-B1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INT (DE) 2021-01-20 EP disclosed
WO-2018138027-A1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICALCOMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-08-02 WO disclosed
WO-2018077699-A1 BENZYLAMINOPYRIDYLCYCLOPROPANECARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2018-05-03 WO disclosed